Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Emerging Risk of Peptides in Supplements LegitScript When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions